In another recent study, HER2 was shown to be expressed in oral cancers, and an anti-HER2 mAb (clone H2Mab-19, mouse IgG2b) showed antitumor activity against SAS and HSC-2 xenografts [33]. This evidence concerns the gene ERBB2 and lip and oral cavity carcinoma.